Drug drug interactions
Showing 1 - 25 of >10,000
Stroke Sequelae, Stroke Trial in Anyang-si (NDC-002)
Completed
- Stroke Sequelae
- Stroke
-
Anyang-si, Korea, Republic ofInsan Medical Foundation Metro Hospital
Oct 22, 2023
Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)
Not yet recruiting
- Healthy
- Camlipixant + Gemfibrozil
- Dabigatran etexilate + camlipixant
-
Québec, Quebec, CanadaSyneos Health
Jul 17, 2023
Diabetes Trial in Seongnam-si (BR3006-1, BR3006-2, BR3006-3)
Not yet recruiting
- Diabetes Mellitus
- BR3006-1
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center(CBMC)
Jul 17, 2023
Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)
Not yet recruiting
- Overweight Subjects
- Obese Subjects
- metformin
- +4 more
-
Beijing, Beijing, ChinaAerospace Center Hospital
Apr 4, 2023
Drug-drug Interaction Trial in Seoul (DWC202211 100mg, DWC202212 5mg, DWC202211 100mg + DWC202212 5mg)
Not yet recruiting
- Drug-drug Interaction
- DWC202211 100mg
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 24, 2023
Healthy Volunteers Trial in Madison (AMG 510, Metformin)
Completed
- Healthy Volunteers
- AMG 510
- Metformin
-
Madison, WisconsinCovance Clinical Research Unit
Jan 9, 2023
Healthy Volunteers Trial in Beijing (GP681, Rosuvastatin, Digoxin)
Recruiting
- Healthy Volunteers
- GP681
- +4 more
-
Beijing, ChinaChina-Japan Friendship Hospital
Mar 28, 2023
Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)
Terminated
- Arthritis, Rheumatoid
- Interaction
-
Esbjerg, Region Of Southern Denmark, Denmark
- +2 more
Jan 20, 2023
Drug-drug Interactions in Patients Treated With Anticancer
Recruiting
- Prostatic Neoplasm
- data collection
-
Besançon, FranceCentre Hospitalier Universitaire de Besançon
Nov 9, 2022
Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, Pirfenidone, Nintedanib)
Completed
- Idiopathic Pulmonary Fibrosis
- HEC585
- +2 more
-
Shanghai, ChinaShanghai Xuhui Central Hospital
May 12, 2022
Epilepsy Trial in Spain, United Kingdom (GWP42003-P 20 mg/kg/Day Dose, Placebo, Clobazam)
Completed
- Epilepsy
- GWP42003-P 20 mg/kg/Day Dose
- +2 more
-
Barcelona, Spain
- +5 more
Sep 22, 2022
Healthy Trial in Wuhan (Tegoprazan, Bismuth, Amoxicilli)
Completed
- Healthy
- Tegoprazan
- +3 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Jun 22, 2023
Healthy Subjects Trial in Lenexa (DZD9008 and intraconazole, DZD9008 and carbamazepine)
Active, not recruiting
- Healthy Subjects
- DZD9008 and intraconazole
- DZD9008 and carbamazepine
-
Lenexa, KansasPharmaceutical Research Associates, Inc.
Jan 18, 2023
Cancer, Advanced Cancer, Advanced Solid Tumor Trial (Drug-Drug Interaction Profile, Drug-Gene Interaction Profile, Standard of
Not yet recruiting
- Cancer
- +2 more
- Drug-Drug Interaction Profile
- +2 more
- (no location specified)
Dec 8, 2021
Drug Interaction Trial in Bangkok (Estradiol valerate 2 mg, cyproterone acetate 25 mg)
Active, not recruiting
- Drug Interaction
- Estradiol valerate 2 mg, cyproterone acetate 25 mg
-
Bangkok, Pathumwan, ThailandInstitute of HIV Research and Innovation (IHRI)
Oct 19, 2022
Rheumatoid Arthritis Trial in Saint Paul (Atorvastatin, Pravastatin, Rosuvastatin)
Completed
- Rheumatoid Arthritis
- Atorvastatin
- +3 more
-
Saint Paul, MinnesotaPrism Research, LLC
May 26, 2022
